KYP-2047

N/A

Report date: 2023/04/17 15:25:41
NME

Base Information

Drug NameKYP-2047
Drug Alias NameKYP-2047
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProlyl endopeptidase inhibitors
TargetsProlyl endopeptidase
Therapy Area/IndicationsNerve DegenerationMemory Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFinland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Kuopio
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Helsinki
Inactive CompaniesUniversity of Kuopio
Active IndicationsNerve Degeneration
Inactive IndicationsMemory Disorders

Other Information

ATC CodeN/A
Related LinksN/A